Cargando…
Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Gastrointestinal Endoscopy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995997/ https://www.ncbi.nlm.nih.gov/pubmed/35279974 http://dx.doi.org/10.5946/ce.2022.063 |
_version_ | 1784684405772517376 |
---|---|
author | Aniwan, Satimai |
author_facet | Aniwan, Satimai |
author_sort | Aniwan, Satimai |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8995997 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Korean Society of Gastrointestinal Endoscopy |
record_format | MEDLINE/PubMed |
spelling | pubmed-89959972022-04-21 Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial Aniwan, Satimai Clin Endosc Commentary Korean Society of Gastrointestinal Endoscopy 2022-03 2022-03-14 /pmc/articles/PMC8995997/ /pubmed/35279974 http://dx.doi.org/10.5946/ce.2022.063 Text en Copyright © 2022 Korean Society of Gastrointestinal Endoscopy https://creativecommons.org/licenses/by-nc/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Commentary Aniwan, Satimai Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial |
title | Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial |
title_full | Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial |
title_fullStr | Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial |
title_full_unstemmed | Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial |
title_short | Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial |
title_sort | fecal calprotectin as a surrogate marker for mucosal healing after initiating the therapeutic anti-tubercular trial |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995997/ https://www.ncbi.nlm.nih.gov/pubmed/35279974 http://dx.doi.org/10.5946/ce.2022.063 |
work_keys_str_mv | AT aniwansatimai fecalcalprotectinasasurrogatemarkerformucosalhealingafterinitiatingthetherapeuticantituberculartrial |